Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Exchange Rate Effect (2019 - 2023)

AVITA Medical (RCEL) has disclosed Exchange Rate Effect for 3 consecutive years, with -$1000.0 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Exchange Rate Effect fell 102.27% year-over-year to -$1000.0, compared with a TTM value of -$16000.0 through Dec 2023, up 38.46%, and an annual FY2023 reading of -$16000.0, up 38.46% over the prior year.
  • Exchange Rate Effect was -$1000.0 for Q4 2023 at AVITA Medical, up from -$18000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $44000.0 in Q4 2022 and bottomed at -$46000.0 in Q2 2022.
  • Average Exchange Rate Effect over 3 years is -$7111.1, with a median of -$6000.0 recorded in 2022.
  • Peak annual rise in Exchange Rate Effect hit 116.67% in 2023, while the deepest fall reached 102.27% in 2023.
  • Year by year, Exchange Rate Effect stood at -$22000.0 in 2019, then soared by 300.0% to $44000.0 in 2022, then plummeted by 102.27% to -$1000.0 in 2023.
  • Business Quant data shows Exchange Rate Effect for RCEL at -$1000.0 in Q4 2023, -$18000.0 in Q3 2023, and $2000.0 in Q2 2023.